{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:44:30Z","timestamp":1747161870260,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["heartandlung.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart &amp; Lung"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.hrtlng.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T17:26:33Z","timestamp":1711128393000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the diagnostic and prognostic ability of ischemia modified albumin in COVID-19"],"prefix":"10.1016","volume":"66","author":[{"given":"Athanasios","family":"Pagonis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Chalkias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7595-5598","authenticated-orcid":false,"given":"Georgios","family":"Mavrovounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tourlakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Marsitopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Papagiannakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kechagia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Makri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Tsolaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Daniil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Pantazopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"journal-title":"Accessed","article-title":"COVID-19 Treatment guidelines","year":"2023","key":"10.1016\/j.hrtlng.2024.03.003_bib0001"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.03.003_bib0002","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.3390\/ijms24032492","article-title":"Microvascular thrombosis as a critical factor in severe COVID-19","volume":"24","author":"Wadowski","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.03.003_bib0003","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10456-020-09753-7","article-title":"Microvascular dysfunction in COVID-19: the MYSTIC study","volume":"24","author":"Rovas","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.hrtlng.2024.03.003_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1038908","article-title":"COVID19 biomarkers: what did we learn from systematic reviews?","volume":"12","author":"Semiz","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.hrtlng.2024.03.003_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.resuscitation.2008.10.035","article-title":"Ischaemia modified albumin in the diagnosis of acute coronary syndromes","volume":"80","author":"Pantazopoulos","year":"2009","journal-title":"Resuscitation"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.03.003_bib0006","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1309\/4BCTG5UCYMQFWBLR","article-title":"Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting","volume":"123","author":"Anwaruddin","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.03.003_bib0007","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/1995-705X.151083","article-title":"The role of ischemia modified albumin in acute pulmonary embolism","volume":"15","author":"Kaya","year":"2014","journal-title":"Heart Views Off J Gulf Heart Assoc"},{"issue":"1\u20132","key":"10.1016\/j.hrtlng.2024.03.003_bib0008","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cca.2005.10.020","article-title":"Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery","volume":"366","author":"Refaai","year":"2006","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.03.003_bib0009","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajem.2007.04.030","article-title":"Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study","volume":"26","author":"Gunduz","year":"2008","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.03.003_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000488188","article-title":"Study of ischemia modified albumin as a biomarker in acute ischaemic stroke","volume":"25","author":"Menon","year":"2018","journal-title":"Ann Neurosci"},{"key":"10.1016\/j.hrtlng.2024.03.003_bib0011","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajem.2021.01.059","article-title":"Association of ischemia modified albumin with mortality in qSOFA positive sepsis patients by sepsis-3 in the emergency department","volume":"44","author":"Park","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"13","key":"10.1016\/j.hrtlng.2024.03.003_bib0012","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.3390\/jcm12134304","article-title":"Analysis of ischemia-modified albumin (IMA) and coagulation parameters in patients with SARS-CoV-2 pneumonia","volume":"12","author":"Saglam","year":"2023","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.hrtlng.2024.03.003_bib0013","first-page":"e28334","article-title":"Evaluation of serum ischemia modified albumin in patients with COVID-19 Pneumonia: a case-control study","volume":"14","author":"Altintas","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.hrtlng.2024.03.003_bib0014","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40291-020-00481-8","article-title":"Soluble urokinase plasminogen activator receptor: a biomarker for predicting complications and critical care admission of COVID-19 Patients","volume":"24","author":"Chalkias","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"7","key":"10.1016\/j.hrtlng.2024.03.003_bib0015","doi-asserted-by":"crossref","first-page":"e13794","DOI":"10.1111\/eci.13794","article-title":"Circulating suPAR associates with severity and in-hospital progression of COVID-19","volume":"52","author":"Chalkias","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"20","key":"10.1016\/j.hrtlng.2024.03.003_bib0016","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.03.003_bib0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2362.2009.02234.x","article-title":"A catalogue of reporting guidelines for health research","volume":"40","author":"Simera","year":"2010","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10.1016\/j.hrtlng.2024.03.003_bib0018","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies*","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/j.hrtlng.2024.03.003_bib0019","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1515\/cclm-2011-0794","article-title":"Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis","volume":"50","author":"Erdem","year":"2012","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"10.1016\/j.hrtlng.2024.03.003_bib0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ajem.2017.03.018","article-title":"A novel biochemical marker for community-acquired pneumonia: ischemia-modified albumin","volume":"35","author":"Bolatkale","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"12","key":"10.1016\/j.hrtlng.2024.03.003_bib0021","doi-asserted-by":"crossref","first-page":"e12514","DOI":"10.1016\/j.heliyon.2022.e12514","article-title":"Value of thiol and ischemia modified albumin (IMA) in predicting mortality in serious COVID-19 pneumonia","volume":"8","author":"Acar","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.03.003_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4274\/tjod.galenos.2022.72929","article-title":"An evaluation of maternal serum dynamic thiol-disulfide homeostasis and ischemia modified albumin changes in pregnant women with COVID-19","volume":"19","author":"Erol","year":"2022","journal-title":"Turk J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.hrtlng.2024.03.003_bib0023","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/ppul.25549","article-title":"Oxidant and antioxidant balance in patients with COVID-19","volume":"56","author":"Aykac","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.03.003_bib0024","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/10641950701885147","article-title":"Ischemia modified albumin in normal pregnancy and preeclampsia","volume":"27","author":"van Rijn","year":"2008","journal-title":"Hypertens Pregnancy"},{"issue":"8","key":"10.1016\/j.hrtlng.2024.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3855\/jidc.17456","article-title":"Could ischemia-modified albumin levels predict the severity of disease in SARS-CoV-2 infection?","volume":"17","author":"Tanr\u0131verdi","year":"2023","journal-title":"J Infect Dev Ctries"},{"issue":"14","key":"10.1016\/j.hrtlng.2024.03.003_bib0026","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.3390\/ijms22147462","article-title":"Oxidative stress and inflammatory biomarkers for the prediction of severity and ICU admission in unselected patients hospitalized with COVID-19","volume":"22","author":"Ducastel","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.hrtlng.2024.03.003_bib0027","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.idnow.2021.06.302","article-title":"Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia","volume":"51","author":"Yildiz","year":"2021","journal-title":"Infect Dis Now"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.03.003_bib0028","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12192-023-01330-3","article-title":"Investigation of inflammation, oxidative stress, and DNA damage in COVID-19 patients","volume":"28","author":"Tepeba\u015f\u0131","year":"2023","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.03.003_bib0029","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1515\/hmbci-2022-0024","article-title":"Hypoxia-inducible factor-1\u03b1 and ischemia-modified albumin levels in intensive care COVID-19 Patients","volume":"43","author":"Yucel","year":"2022","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"7","key":"10.1016\/j.hrtlng.2024.03.003_bib0030","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1681\/ASN.2020040419","article-title":"Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology","volume":"31","author":"Batlle","year":"2020","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.03.003_bib0031","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.hrtlng.2024.03.003_bib0032","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2020.06.029","article-title":"The hypercoagulable state in COVID-19: incidence, pathophysiology, and management","volume":"194","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.hrtlng.2024.03.003_bib0033","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/v15020553","article-title":"Hyperinflammatory response in COVID-19: a systematic review","volume":"15","author":"Silva","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.hrtlng.2024.03.003_bib0034","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13054-021-03803-2","article-title":"Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units","volume":"25","author":"Mesquida","year":"2021","journal-title":"Crit Care Lond Engl"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.03.003_bib0035","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/jcm11041032","article-title":"Microcirculatory alterations in critically Ill patients with COVID-19-associated acute respiratory distress syndrome","volume":"11","author":"Di Dedda","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.03.003_bib0036","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10456-023-09885-6","article-title":"Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation","volume":"26","author":"Kuchler","year":"2023","journal-title":"Angiogenesis"},{"issue":"11","key":"10.1016\/j.hrtlng.2024.03.003_bib0037","first-page":"1905","article-title":"Microvascular alteration in COVID-19 documented by nailfold capillaroscopy","volume":"13","author":"Mondini","year":"2023","journal-title":"Diagn Basel Switz"},{"issue":"4","key":"10.1016\/j.hrtlng.2024.03.003_bib0038","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/jcm13040967","article-title":"Predicting the Outcome of Patients with Severe COVID-19 with Simple Inflammatory Biomarkers: the Utility of Novel Combined Scores-Results from a European Tertiary\/Referral Centre","volume":"13","author":"Ntalouka","year":"2024","journal-title":"J Clin Med"}],"container-title":["Heart &amp; Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956324000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T12:23:04Z","timestamp":1715430184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956324000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"alternative-id":["S0147956324000438"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.03.003","relation":{},"ISSN":["0147-9563"],"issn-type":[{"type":"print","value":"0147-9563"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the diagnostic and prognostic ability of ischemia modified albumin in COVID-19","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}